Clinical Nutrition Market – By Product, By Consumer, By Application, By Dosage Form, By Distribution Channel — Global Forecast, 2025 – 2034

Clinical Nutrition Market Size

The global clinical nutrition market was estimated at USD 58.6 billion in 2024. The market is expected to grow from USD 63.7 billion in 2025 to USD 161.2 billion in 2034, growing at a CAGR of 10.9%, according to the latest report published by Global Market Insights Inc. The market is undergoing rapid evolution, driven by the increasing significance of nutrition in promoting overall health and reducing the risk of chronic conditions such as diabetes, cancer, and cardiovascular diseases (CVDs). The high disease rates embrace the shift towards effective nutrition solutions that provide personalized dietary guidance and medical nutrition therapy.
 

In addition, several studies highlighted the significant role of clinical nutrition in enhancing health outcomes, particularly when traditional dietary consumption fails to meet essential nutritional needs. This has led to the growing shift towards nutritional therapies with increasing demand for personalized nutritional solutions offering targeted support based on individual health profiles, significantly boosting market growth.
 

Clinical nutrition is a specialized area dedicated to managing an individual’s nutritional needs through personalized diet or medical nutrition products aimed at treating health conditions, supporting recovery, and improving overall health outcomes. The major key players in the industry include Abbott (Abbott Nutrition), Nestle Health Science, Danone, and Fresenius Kabi. These companies emphasize innovations, tailored nutrition plans, developing disease-specific nutritional products, and expanded nutritional support through home healthcare services.
 

The market substantially increased from USD 47.9 billion in 2021 to USD 53.9 billion in 2023. This growth trajectory was mainly fueled by growing awareness among individuals towards immune health and spurring the adoption of personalized nutrition therapies. The COVID-19 pandemic played a pivotal role in highlighting the significance of proper nutrition in preventing health complications and strengthening immunity, which spurred growth in both hospital-based and home-based clinical nutrition therapy. As a result, healthcare providers commenced prioritizing nutrition-based interventions as part of overall treatment plans, driving investments and product innovation in the clinical nutrition industry.
 

Aging-related changes propel the incidence of nutritional deficiencies in the elderly population caused due to reduced appetite, difficulty in swallowing, making them a prime candidate for nutritional therapy. With healthcare systems placing a greater emphasis on preventive care and healthy aging, the global demand for medical nutrition products, including supplements, enteral nutrition, and disease-specific formulations, is steadily rising.
 

Clinical nutrition plays a significant role in patient care across hospitals, long-term care facilities, and home healthcare settings. It encompasses a broad spectrum of products categorized into infant nutrition, enteral nutrition and parenteral nutrition. These specialized formulations are designed to manage a wide range of health conditions including malnutrition, cancer-related nutritional needs, metabolic disorders, neurological diseases, and gastrointestinal (GI) disorders. By addressing complicated medical needs, these solutions support overall health maintenance and improve outcomes for patients with critical health needs.
 

Clinical Nutrition Market Trends

• The global clinical nutrition market is poised to undergo a revolution driven by the growing need for personalized and precision nutrition and rapid advancement enabled by digital health technologies, artificial intelligence (AI) in healthcare, and nutrigenomics.
   
• This shift is fundamentally altering the clinical nutrition landscape from generalized dietary guidelines towards tailored interventions based on an individual's genetic composition, microbiome composition, metabolic profile, and current health status.
   
• In addition, AI-driven health monitoring tools and connected devices support the transformative trend of nutritional therapies by allowing real-time tracking of patient health indicators like blood glucose level, muscle mass, and nutrient deficiencies, leading to timely adjustments in nutritional plans.
   
• Further, the expanding research in nutrigenomics and metabolomics is revealing the genetic variations influencing nutrient metabolism and disease risk, allowing healthcare providers to design targeted nutritional therapies that improve clinical outcomes for patients with chronic diseases, malnutrition, or specific metabolic disorders.
   
• Moreover, the growing demand for precision nutrition has become more integrated into mainstream healthcare, and clinical nutrition products ranging from enteral and parenteral formulations to specialized supplements will be increasingly designed to meet the unique biological and clinical needs of patients.
   
• This paradigm shift enhances the therapeutic efficacy, positioning personalized clinical nutrition as a cornerstone of preventive and therapeutic healthcare, driving sustained market growth.
   

Clinical Nutrition Market Analysis

Based on the product, the global clinical nutrition market is segmented into infant nutrition, enteral nutrition, and parenteral nutrition. The infant nutrition segment accounted for the largest revenue of USD 32.3 billion in 2024, fueled by a rising need for specialized dietary support for infants and neonates. The segment is expected to exceed USD 90.9 billion by 2034, growing at a CAGR of 11.1% during the forecast period.
 

• The growing demand for infant nutrition is largely driven by increased parental awareness of its vital role in early health development.
   
• Additionally, factors such as lactose intolerance, allergies, and premature births further contribute to the need for specialized nutritional intake.
   
• This upsurge in demand has further driven the advancements in infant formulas by improving product efficacy and health outcomes, particularly enriched with probiotics and other essential nutrients.
   
• Furthermore, growing acceptance of infant feeding is supported by favorable government policies and expanding availability of innovative products across retail and healthcare channels. These combined factors reinforce their dominance, reflecting strong and sustained demand within the clinical nutrition market.
   
• Moreover, the enteral nutrition segment is projected to grow at a rate of 10.7%, driven by its effectiveness in delivering essential nutrients directly to the gastrointestinal tract. This method is particularly beneficial for patients suffering from chronic diseases, cancer, or neurological disorders. The segmental growth is further accelerated by a rise in hospital admissions and a growing preference for home-based enteral feeding.
   

Based on consumer, the global clinical nutrition market is segmented into pediatric and adult. The pediatric segment accounted for the highest market share of 59.5% in 2024 due to the rising emphasis on child health and nutrition.
 

• The significant demand for pediatric nutrition is primarily fueled due to several factors including the significance of nutrition in children's development, coupled with the increase in premature births, congenital disorders, pediatric malnutrition, and obesity.
   
• Additionally, government initiatives and hospital programs intended to enhance pediatric care further boost market growth.
   
• For instance, in August 2025, a self-care campaign was conducted by an NGO, in partnership with Plan India, that aimed at educating tribal children about nutrition, disease prevention and overall health through diet diversification, physical activity, and hygiene. This initiative marked a vital step toward empowering tribal communities with knowledge and practices that support healthier, more resilient lives.
   
• Similarly, in September 2023, the National Nutrition Council of the Philippines initiated the Philippine Plan of Action for Nutrition (PPAN) 2023-2028. This strategy, with a six-year plan, aimed to lessen childhood obesity and the burden of malnutrition. Such government initiatives bolster revolution in clinical nutrition products to address the growing pediatric disease burden and boost investment in research, expanding market opportunities.
   
• On the other hand, the adult segment is poised to grow at a significant rate due to the rising chronic conditions prevalent in adults. As the global population ages, the need for nutritional support rises, particularly for individuals managing long-term health conditions. This demand is further amplified by a growing shift toward home healthcare, where patients seek convenient and effective nutritional solutions outside traditional clinical settings.
   

Based on application, the global clinical nutrition market is segmented into malnutrition, cancer nutrition, metabolic disorders, neurological diseases, gastrointestinal disorders, and other applications. The metabolic disorders segment accounted for the highest market share in 2024 and is expected to reach USD 50.9 billion by 2034 due to the higher prevalence of metabolic conditions likely to surge the need for nutritional support, contributing to market expansion.
 

• The increasing prevalence of metabolic disorders is driven by sedentary lifestyle, dietary habits, and genetic predisposition. This rise necessitates the need for a personalized dietary strategy.
   
• Clinical nutrition leads as a cornerstone in providing nutritional support in maintaining blood-glucose level, supporting weight management, and providing essential nutrients in metabolically compromised individuals, making it preferable for treatment.
   
• As standard diets frequently fall short, while personalized nutrition plans, based on genetics, gut microbiota, and lifestyle, support managing the symptoms, preventing complications, and improving outcomes.
   
• For instance, as reported by the WHO, the global diabetes prevalence is rising rapidly, with more than 537 million adults aged 20–79 suffering from diabetes in 2021. This figure is projected to reach 783 million by 2045, a 46% increase. This projected growth is expected to surge the preventive and management strategies, driving the demand for nutritional support.
   
• Additionally, rising healthcare spending and the growing awareness of preventive care and long-term disease management contribute to the dominance of the metabolic disorders segment, emphasizing the need for clinical nutrition.
   
• On the other hand, the GI disorders segment is projected to grow at a significant rate of 11.4%. This anticipated growth is likely to be driven by the increasing incidence of GI-associated conditions such as Crohn’s disease, ulcerative colitis (UC), and irritable bowel syndrome (IBS). These rising cases are expected to enhance the need for easily digestible nutrition-oriented therapies, accelerating growth in this segment.
   

Based on dosage form, the global clinical nutrition market is segmented into powder, liquid, and solid. The liquid segment accounted for the highest market share of 48.7% in 2024 and is expected to grow at a CAGR of 10.5% during the analysis period.
 

• Liquid formulation gain popularity due to its ease of consumption, particularly for patients with difficulties in swallowing or GI disorders.
   
• These formulations offer rapid absorption and faster digestion, ideal for hospital and home healthcare.
   
• Additionally, their versatility in dosage and nutrient customization makes them the preferred choice for wide range of demographics and chronic conditions.
   
• Further, advancements in flavoring and packaging have improved patient compliance and convenience.
   
• On the other hand, the solid formulation segment is poised to witness significant growth due to their longer shelf life, and ease of storage and transport. Rising consumer preference for tablets, powders, and granules, notably among outpatients and home care settings, along with advancements in formulation technology, are likely to spur the need for solid formulations in the coming years.
   

Based on the distribution channel, the global clinical nutrition market is segmented into offline channels and online channels. The offline channels segment accounted for the largest revenue of USD 48.4 billion in 2024 due to the strong presence in hospital pharmacies and healthcare institutions.
 

• The offline channels segment is further categorized into hospital pharmacies, retail pharmacies, and other offline channels.
   
• Healthcare professionals often recommend and dispense clinical nutrition products through hospital pharmacies or clinics, ensuring trust and reliability in purchase.
   
• Additionally, patients undergoing treatment are more likely to favor face-to-face consultations and product access from established medical facilities.
   
• The offline segment benefits further from expert guidance, instant product availability, and patient ease with traditional purchasing channels, reinforcing its dominance in the market.
   
• On the other hand, online channels are poised to witness significant growth due to rising consumer preference for convenience, home delivery, and wider product availability. Increased internet penetration, telehealth adoption, and e-commerce platforms offering clinical nutrition products are driving digital sales, exclusively among tech-savvy and home care-dependent populations, further expanding their growth.
   

North America clinical nutrition market

North America dominated the global clinical nutrition market with the highest market share of 27.8% in 2024.
 

• The region held the largest share due to its advanced healthcare infrastructure, high awareness of nutritional therapies, and growing prevalence of chronic diseases.
   
• The region benefits from strong regulatory support and widespread adoption of clinical nutrition in hospitals and home care settings.
   
• Additionally, the presence of leading market players and increased investment in research and development contribute to the region’s leadership in driving innovation and expanding access to specialized nutritional products.
   

In 2024, the U.S. clinical nutrition market accounted for USD 14.7 billion in revenue from USD 14.3 billion in 2023 and is anticipated to grow at a CAGR of 10.1% between 2025 and 2034.
 

• The U.S. has witnessed substantial growth due to its advanced healthcare system, high prevalence of chronic disease and growing aging population.
   
• For instance, according to the CDC, approximately 38.4 million U.S. people were living with diabetes in 2021. These statistics underscore the need for effective diabetes management solutions with a focus on dietary control and specialized nutrition.
   
• As people are becoming more aware of the necessity of nutritional support in disease management and recovery, the demand for specialized nutritional support has grown.
   
• Further, the country also benefits from strong regulatory frameworks, widespread insurance coverage, and significant investment in research and development.
   
• Additionally, the presence of major clinical nutrition companies and a well-established distribution network further solidifies the U.S.'s leading position in the regional market.
   

Europe clinical nutrition market

Germany is poised to achieve significant growth in the European market.
 

• The country's growth is driven by high healthcare awareness, increasing prevalence of chronic diseases like diabetes and cardiovascular conditions, and one of the world's most rapidly aging populations.
   
• The well-established healthcare infrastructure, strong government healthcare policies, and high disposable incomes are contributing to steady market growth.
   
• Additionally, Germany has rigorous food supplement and medical nutrition regulations through agencies like BfR (Federal Institute for Risk Assessment), ensuring high product quality standards but also creating barriers for new market entrants.
   
• Germany's comprehensive healthcare insurance system provides better coverage for clinical nutrition products compared to many other markets, increasing accessibility for patients.
   

Asia Pacific clinical nutrition market

Asia Pacific is poised to grow at a significant rate over the next few years.
 

• The region’s growth is driven by rising healthcare awareness, increasing prevalence of chronic diseases, and a rapidly aging population.
   
• The expanding healthcare infrastructure, government initiatives, and rising disposable incomes are contributing to market growth.
   
• Additionally, the key countries like China, India, and Japan are witnessing growing demand for nutritional support in both hospital and home care settings.
   
• Further, the presence of emerging local players and increased investment in clinical nutrition research contribute to the region’s dynamic expansion.
   

China is anticipated to grow significantly within the Asia Pacific clinical nutrition market.
 

• The expanding healthcare infrastructure, rising awareness of nutritional therapies, and increasing prevalence of chronic diseases has fueled the China growth in the market.
   
• The country’s large aging population and growing middle class are driving demand for specialized nutrition products in both hospital and home care settings.
   
• Further, growing government initiatives to improve healthcare access and nutrition standards, along with rising investments from domestic and international players, are further accelerating market expansion and innovation in clinical nutrition across China.
   

Latin America clinical nutrition market

Brazil is projected to witness significant growth in Latin America market in the coming years.
 

• The country faces a unique ‘nutrition transition’ where traditional malnutrition challenges coexist with rising obesity rates, creating dual market opportunities.
   
• According to recent data, 36% of Brazil's adult population was overweight and 26% was obese in 2023 as per the article published by GTAI, indicating substantial need for therapeutic nutrition interventions.
   
• Further, the acceptance of specialized nutrition products such as enteral and parenteral nutrition is also rising, particularly in hospitals and home care settings, positioning Brazil as a key regional player in the evolving clinical nutrition landscape.
   
• Additionally, entry of international and local market players is likely to boost innovation and availability of clinical nutrition products, positioning Brazil as a key growth driver in the region.
   

Middle East & Africa clinical nutrition market

Saudi Arabia is anticipated to grow in the Middle East and African market.
 

• Saudi Arabia is anticipated to grow steadily, driven by increasing healthcare investments, rising awareness of nutritional therapies, and a growing burden of chronic diseases.
   
• The country’s expanding healthcare infrastructure and government initiatives aimed at improving public health are fostering demand for clinical nutrition products.
   
• Additionally, the rising aging population and growing interest in preventive healthcare are expected to support market growth, positioning Saudi Arabia as a key emerging player in the region’s clinical nutrition landscape.
   

Clinical Nutrition Market Share

The leading companies dominating the global market include Abbott (Abbott Nutrition), Nestle Health Science, Danone, and Fresenius Kabi, holding ~65% of the market share. These companies maintain their prominence by focusing on disease-specific formulations, home-based care, and digital health integration.
 

The market comprises a mix of established and emerging players. These companies are leveraging digital health platforms and AI-driven nutrients dosing to enhance patient outcomes and streamline delivery. However, challenges persist, including stringent regulatory approvals, limited insurance coverage for home parenteral nutrition, and supply chain disruptions. Furthermore, the market is evolving toward personalized, plant-based, and functional nutrition, creating opportunities for innovation and strategic partnerships among both established and emerging players. These strategic initiatives enable companies to retain their market position and thrive amid competition.
 

Clinical Nutrition Market Companies

A few of the prominent players operating in the clinical nutrition industry include:

• Abbott (Abbott Nutrition)
• Aculife Healthcare
• B. Braun
• BASF
• Baxter
• Danone
• Fresenius Kabi
• Grifols SA
• Hero Nutritionals
• Hormel Foods
• Mead Johnson (Reckitt Benckiser)
• Meiji Holdings
• Nestle Health Science
• Perrigo

 

• Abbott

Abbott offers a robust portfolio including products such as Ensure and Pedialyte supported by extensive clinical research. The company's nutrition business strength lies in both pediatric and adult nutrition, with a strong focus on chronic disease support. Abbott’s innovation in personalized nutrition and global reach strengthened its position in the global market.

• Nestle Health Science

Nestle Health Science specializes in disease-specific nutrition, including metabolic disorders and cancer support. Its strategic acquisitions and collaborations, along with integration of digital platforms, have enhanced its offering in enhanced care. The company’s focus on sustainability, innovation, and a broad product portfolio positions it among the leaders in the evolving clinical nutrition landscape.

• Danone

Danone’s Nutricia division specializes in enteral nutrition for infants, the elderly, and chronic disease patients worldwide. The company focuses on plant-based, allergen-free formulations with strong clinical backing. In addition, Danone’s investment in the medical nutrition sector and sustainability initiatives reinforces its competitive edge in therapeutic dietary solutions.

• Fresenius Kabi

Fresenius Kabi stands out for its expertise in parenteral nutrition and infusion therapies. It offers inclusive solutions for hospital and home care settings. Its focus on safety, innovation, and global manufacturing capabilities makes it a key player in the global clinical nutrition sector.
 

Clinical Nutrition Industry News:

• In January 2025, Otsuka Pharmaceutical introduced ENOSOLID semi-solid enteral nutrition formula, a nutrient-rich formulation that fits in with Japanese diet. It supports patients that require reduced maintenance energy with its balance of vitamins, trace elements, and essential nutrients. This is an innovative step in nutritional care for patients with special energy requirements which also aligns with what is culturally accepted in their diet.
   
• In July 2024, Vitaflo, a Nestle Health Science subsidiary, invested over EUR 8 million to expand its Rosbach vor der Hohe facility near Frankfurt, Germany. The move boosts their global distribution to 40+ countries. This expansion strengthens Vitaflo’s commitment to supporting individuals with rare metabolic disorders through improved access to essential medical nutrition.
   
• In May 2024, Baxter received the U.S. FDA approval for Clinolipid (lipid injectable emulsion) used in pediatric patients, including preterm and term neonates. Clinolipid is a mixed oil lipid emulsion essential to deliver fatty acids and calories. It is used in parenteral nutrition when oral or enteral nutrition is inadequate or contraindicated. This approval aims to offer an expanded nutritional support to the neonates or pediatric patients with inadequate response to the oral and enteral nutrition, improving the clinical outcome.
   

The clinical nutrition market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 – 2034 for the following segments:

Market, By Product

• Infant nutrition
  • Milk-based
  • Soy-based
  • Organic formula
  • Other infant formulas
• Enteral nutrition
  • Standard composition
  • Disease-specific composition
  • Elemental formulas
  • Other enteral formulas
• Parenteral nutrition
  • Amino acids
  • Fats
  • Carbohydrates
  • Vitamins & minerals
  • Other parenteral formulas

Market, By Consumer

• Pediatric
• Adult

Market, By Application

• Malnutrition
• Cancer nutrition
• Metabolic disorders
• Neurological diseases
• Gastrointestinal disorder
• Other applications

Market, By Dosage Form

• Powder
• Liquid
• Solid

Market, By Distribution Channel

• Offline channels
  • Hospital pharmacies
  • Retail pharmacies
  • Other offline channels
• Online channels

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE